Skip to main navigation Skip to search Skip to main content

Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2

  • G. H. Lee
  • , S. H. Park
  • , B. M. Song
  • , D. M. Kim
  • , H. J. Han
  • , J. Y. Park
  • , Y. W. Jo
  • , M. Y. Hwang
  • , K. T. Sim
  • , S. M. Kang*
  • , D. Tark
  • *Corresponding author for this work
  • Jeonbuk National University
  • National Institute of Environmental Research

Research output: Contribution to journalJournal articlepeer-review

Abstract

Background: Disinfection is one of the most effective ways to block the rapid transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Due to the prolonged coronavirus disease 2019 (COVID-19) pandemic, disinfectants have become crucial to prevent person-to-person transmission and decontaminate hands, clothes, facilities and equipment. However, there is a lack of accurate information on the virucidal activity of commercial disinfectants. Aim: To evaluate the virucidal efficacy of 72 commercially available disinfectants constituting 16 types of ingredients against SARS-CoV-2. Methods: SARS-CoV-2 was tested with various concentrations of disinfectants at indicated exposure time points as recommended by the manufacturers. The 50% tissue culture infectious dose assay was used to calculate virus titre, and trypan blue staining and CCK-8 were used to assess cell viability after 3–5 days of SARS-CoV-2 infection. Findings: This study found that disinfectants based on 83% ethanol, 60% propanol/ethanol, 0.00108–0.0011% sodium dichloroisocyanurate and 0.497% potassium peroxymonosulfate inactivated SARS-CoV-2 effectively and safely. Although disinfectants based on 0.05–0.4% benzalkonium chloride (BAC), 0.02–0.07% quaternary ammonium compound (QAC; 1:1), 0.4% BAC/didecyldimethylammonium chloride (DDAC), 0.28% benzethonium chloride concentrate/2-propanol, 0.0205–0.14% DDAC/polyhexamethylene biguanide hydrochloride (PHMB) and 0.5% hydrogen peroxide inactivated SARS-CoV-2 effectively, they exhibited cytotoxicity. Conversely, disinfectants based on 0.04–4% QAC (2:3), 0.00625% BAC/DDAC/PHMB, and 0.0205–0.14% and 0.0173% peracetic acid showed approximately 50% virucidal efficacy with no cytotoxicity. Citric acid (0.4%) did not inactivate SARS-CoV-2. Conclusion: These results indicate that most commercially available disinfectants exert a disinfectant effect against SARS-CoV-2. However, re-evaluation of the effective concentration and exposure time of certain disinfectants is needed, especially citric acid and peracetic acid.

Original languageEnglish
Pages (from-to)12-22
Number of pages11
JournalJournal of Hospital Infection
Volume131
DOIs
StatePublished - 2023.01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cytotoxicity
  • Disinfectants
  • SARS-CoV-2
  • Virucidal efficacy

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Comparative efficacy evaluation of disinfectants against severe acute respiratory syndrome coronavirus-2'. Together they form a unique fingerprint.

Cite this